This was not a slow year for the mesothelioma community. In 2014, research progressed by bounds and lives were invariably changed. Looking back is important to remember those...
Read Post
Are Mesothelioma Doctors Shifting Their Opinions on Surgery?
Doctors, Treatment
By: Andrew Devine
December 26, 2014
Surgery for pleural mesothelioma may be reaching a turning point. There has been debate about which surgical treatments are more effective for years. The extrapleural...
Read Post
Researchers Make Breakthrough in Understanding Mesothelioma
Mesothelioma Research, News
By: Andrew Devine
December 18, 2014
Researchers at the University of Hawaii Cancer Center have discovered that mesothelioma is the result of mutations in more than one cell. This seemingly minor discovery could open...
Read Post
3 Treatments That Could Revolutionize Mesothelioma Therapy
Awareness, Mesothelioma Research, Treatment
By: Andrew Devine
December 5, 2014
Treatment for pleural mesothelioma is reaching a turning point. For years, the only strategies with curative potential have been surgery and chemotherapy. Surgery has been...
Read Post
Why Doctors Are Hopeful About Large Mesothelioma Clinical Trial
Clinical Trials, Mesothelioma Research, News
By: Andrew Devine
November 25, 2014
Over 500 patients have enrolled in a Phase II clinical trial for pleural and peritoneal mesothelioma. The trial is investigating tremelimumab, an emerging immunotherapy that may...
Read Post
Report Reveals Why Some Women May Get Mesothelioma
Awareness, News
By: Andrew Devine
November 18, 2014
Women are over four times less likely to develop mesothelioma in their lifetime than men are. Most people are exposed to asbestos, the only cause of mesothelioma, in trade...
Read Post
How Genetically Modified Cells Attack Mesothelioma
Clinical Trials, Mesothelioma Research, News
By: Andrew Devine
November 7, 2014
The next experimental treatment for pleural mesothelioma is on the horizon. Scientists at Memorial Sloan-Kettering (MSK) have developed a way to genetically modify white blood...
Read Post
Doctor Calls on Pharmaceutical Companies for More Mesothelioma Research
Clinical Trials, Doctors
By: Andrew Devine
October 30, 2014
Mesothelioma specialist Dr. Lee Krug recently wrote an open letter to pharmaceutical companies across the country with this message — large enrollment clinical trials are...
Read Post
Experimental Mesothelioma Drug Makes Speedy Progress
Clinical Trials, Doctors
By: Andrew Devine
October 24, 2014
An exciting new immunotherapy treatment, CRS-207, continues to produce promising results. The pharmaceutical company that developed the drug, Aduro Biotech, released the results...
Read Post
3 Things Mesothelioma Patients Can Do to Live Longer
Awareness, Clinical Trials, Doctors
By: Andrew Devine
October 18, 2014
A diagnosis of mesothelioma can leave many patients feeling helpless–as if their disease is completely out of their control. But there are ways for every patient to take...
Read Post